therapeutics

Amberstone Biosciences, an emerging biotherapeutics company with unique expertise in conditionally active immunotherapeutics, announced the completion…

WuXi Biologics, a global company with leading open-access biologics technology platforms, and ImmuneOncia Therapeutics, Inc., a clinical-stage,…

Palantir Technologies Inc., a leading builder of operating systems for the modern enterprise, and Dewpoint Therapeutics , the leading biomolecular…

Providence Therapeutics announced the signing of a Memorandum of Understanding (MOU) with VaxThera S.A.S and the Ministry of Health and Social…

20n Bio (20n), an artificial intelligence (AI)-powered drug discovery company focusing on designing new proteins for therapeutics, has raised a $3.3…

ixlayer recognized for achievements in the screening, monitoring and diagnostics category of the internet software and services sector CB Insights …

StemiRNA, a leader in research and development of mRNA therapeutics, welcomes Dr. Jack Hu as Chief Financial Officer. Dr. Hu brings nearly two decades…

XNK Therapeutics AB ("XNK") announced it will perform a proof of concept study in acute myeloid leukemia (AML) using patient samples from The…

Underscores the Company's ambition to harness the power of ultrasound in precision therapeutics amplification Exact Therapeutics AS, a clinical-stage…

Jeito Capital co-leads $156 million oversubscribed Series B financing in Quell Therapeutics Quell Therapeutics is the world leader in developing…